Masimo Corporation Overview
Company Headquarter: US
Founded: 1989
Workforce: ~4000
Company Working: Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, respiration rate from the pleth, noninvasively monitor hemoglobin concentration, carboxyhemoglobin and methemoglobin saturation, monitor arterial oxygen saturation, and acoustic respiration rate and calculates oxygen content and oxygen reserve index.
Strategy
The company is expanding its mission to focus on improving patient outcomes and reducing the cost of care through all possible means
The company continues to advance technology and products in its core business of noninvasive monitoring while also expanding its portfolio in new marketsThe company believes that its growth will be driven by internal R&D and looks for unique opportunities to supplement those efforts with external licensing and acquisitions
